Eric J. Hyllengren - 04 Mar 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, CFO
Signature
/s/ John Chao, Attorney-in-Fact for Eric J. Hyllengren
Issuer symbol
ATRA
Transactions as of
04 Mar 2024
Net transactions value
-$4,810
Form type
4
Filing time
06 Mar 2024, 18:17:15 UTC
Previous filing
09 Jan 2024
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $1,054 -1,462 -0.21% $0.7210 679,536 04 Mar 2024 Direct F1, F2
transaction ATRA Common Stock Sale $3,756 -5,217 -0.77% $0.7200 674,319 04 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.